Sign up to save your podcasts
Or
Share 1st Patient Enrolled in Trial Testing Ofev on Post-COVID-19 PF
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
1st Patient Enrolled in Trial Testing Ofev on Post-COVID-19 PF
Pulmonary Fibrosis News Columnist and Forum Moderator Charlene Marshall reads an article summarizing a new trial taking place in partnership between Boehringer Ingelheim and Mount Sinai Hospital. The study will investigate the effect of Ofev on patients who develop lung fibrosis as a result of a COVID-19 infection.
Are you interested in learning more about Pulmonary Fibrosis? If so, please visit: https://pulmonaryfibrosisnews.com
View all episodes
By Pulmonary Fibrosis NewsPulmonary Fibrosis News Columnist and Forum Moderator Charlene Marshall reads an article summarizing a new trial taking place in partnership between Boehringer Ingelheim and Mount Sinai Hospital. The study will investigate the effect of Ofev on patients who develop lung fibrosis as a result of a COVID-19 infection.
Are you interested in learning more about Pulmonary Fibrosis? If so, please visit: https://pulmonaryfibrosisnews.com